Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-030312
Filing Date
2024-12-31
Accepted
2024-12-31 16:15:04
Documents
1
Period of Report
2023-10-01

Document Format Files

Seq Description Document Type Size
1 form4-12312024_041201.html 4  
1 form4-12312024_041201.xml 4 6092
  Complete submission text file 0001415889-24-030312.txt   7747
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Issuer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ZURA BIO INC. 4225 EXECUTIVE SQUARE, SUITE 600 LA JOLLA CA 92037
Business Address
Davis Kim (Reporting) CIK: 0001965590 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40598 | Film No.: 241593176